Tower Research Capital (TRC)’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-16,025
| Closed | -$20.8K | – | 5202 |
|
|
2025
Q2 | $20.8K | Buy |
16,025
+7,658
| +92% | +$9.21K | ﹤0.01% | 3657 |
|
|
2025
Q1 | $11.6K | Buy |
8,367
+4,151
| +98% | +$9.09K | ﹤0.01% | 3523 |
|
|
2024
Q4 | $9.65K | Buy |
4,216
+2,518
| +148% | +$6.67K | ﹤0.01% | 3889 |
|
|
2024
Q3 | $4.62K | Sell |
1,698
-5,029
| -75% | -$12.3K | ﹤0.01% | 4474 |
|
|
2024
Q2 | $15.7K | Buy |
6,727
+5,414
| +412% | +$17.3K | ﹤0.01% | 3896 |
|
|
2024
Q1 | $6.16K | Sell |
1,313
-9,095
| -87% | -$47.2K | ﹤0.01% | 4423 |
|
|
2023
Q4 | $50.8K | Buy |
10,408
+7,746
| +291% | +$32.2K | ﹤0.01% | 3126 |
|
|
2023
Q3 | $12.4K | Buy |
2,662
+2,108
| +381% | +$12.1K | ﹤0.01% | 3895 |
|
|
2023
Q2 | $4.09K | Sell |
554
-689
| -55% | -$4.6K | ﹤0.01% | 4988 |
|
|
2023
Q1 | $10K | Sell |
1,243
-377
| -23% | -$3.94K | ﹤0.01% | 4319 |
|
|
2022
Q4 | $16K | Buy |
1,620
+121
| +8% | +$1.49K | ﹤0.01% | 3316 |
|
|
2022
Q3 | $18K | Buy |
1,499
+306
| +26% | +$4.03K | ﹤0.01% | 3998 |
|
|
2022
Q2 | $15K | Sell |
1,193
-411
| -26% | -$4.26K | ﹤0.01% | 4050 |
|
|
2022
Q1 | $17K | Buy |
1,604
+498
| +45% | +$5.78K | ﹤0.01% | 3672 |
|
|
2021
Q4 | $17K | Buy |
1,106
+213
| +24% | +$2.79K | ﹤0.01% | 3827 |
|
|
2021
Q3 | $12K | Sell |
893
-1,905
| -68% | -$31.9K | ﹤0.01% | 4131 |
|
|
2021
Q2 | $54K | Buy |
+2,798
| New | +$57.8K | ﹤0.01% | 2961 |
|
Tower Research Capital (TRC)'s AKYA Position: Q3 2025 in Review
Tower Research Capital (TRC) sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 16,025 shares — an estimated $20.8K sold.
Tower Research Capital (TRC) first reported a position in AKYA in Q2 2021 and held it in 17 quarters. The position peaked at $54K in Q2 2021. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- Tower Research Capital (TRC) reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 16,025 Akoya BioSciences shares in Q3 2025, an estimated $20.8K.
- Tower Research Capital (TRC) first reported a position in Akoya BioSciences in Q2 2021 and held it in 17 quarters.
- Tower Research Capital (TRC)'s Akoya BioSciences position peaked at $54K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.